| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 8 | +75.00% | -3.46% | +0.33% | -3.79% | -4.48% | — |
| 14d | 8 | +62.50% | -1.75% | +0.20% | -1.95% | -8.98% | — |
| 30d | 8 | +62.50% | +3.24% | -0.46% | +3.70% | -0.94% | — |
| 60d | 8 | +37.50% | +2.79% | +0.65% | +2.14% | +9.89% | — |
| 90d | 8 | +62.50% | -8.63% | +0.51% | -9.14% | -21.36% | — |
| 180d | 8 | +50.00% | -1.56% | +7.39% | -8.95% | -5.39% | — |
| 1y | 8(1 pending) | +57.14% | +0.22% | +16.25% | -16.02% | -14.82% | — |
| 2y | 8(8 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 136,500 | — | — | 136,500 | Jan 26, 2026 | Jan 28, 2026 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 937 | $6.98 | $6.5K | 52,493 | Jul 28, 2025 | Jul 30, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 937 | — | — | 29,377 | Jul 28, 2025 | Jul 30, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 937 | $1.29 | $1.2K | 53,430 | Jul 28, 2025 | Jul 30, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 781 | $5.04 | $3.9K | 52,493 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 781 | $1.29 | $1.0K | 53,274 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 781 | — | — | 30,314 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 13,905 | $1.29 | $17.9K | 97,809 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASE Chief Medical Officer | 4,584 | $3.75 | $17.2K | 83,904 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 13,905 | — | — | 31,095 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 4,584 | — | — | 195,416 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 45,316 | $8.76 | $397.0K | 52,493 | Mar 18, 2025 | Mar 20, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 107,250 | — | — | 107,250 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 10,428 | $7.23 | $75.3K | 79,320 | Jan 15, 2025 | Jan 17, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 10,799 | $8.22 | $88.7K | 89,748 | Jan 8, 2025 | Jan 10, 2025 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 13,935 | $4.56 | $63.5K | 100,547 | Nov 29, 2024 | Dec 3, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 10,875 | $6.47 | $70.4K | 114,482 | Jul 17, 2024 | Jul 19, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 9,769 | $5.97 | $58.4K | 125,357 | Jul 11, 2024 | Jul 15, 2024 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | SALE Chief Medical Officer | 12,175 | $0.90 | $11.0K | 135,126 | Nov 28, 2023 | Nov 30, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 88,822 | — | — | 147,301 | Nov 26, 2023 | Nov 28, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 45,000 | — | — | 45,000 | Apr 28, 2023 | May 2, 2023 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 58,479 | — | — | 58,479 | Nov 28, 2022 | Nov 30, 2022 ↗ | View → |
| CADL CANDEL THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Sep 12, 2022 | Sep 14, 2022 ↗ | View → |